ABB  Vol.3 No.6 A , October 2012
Pentoxifylline suppressed LPS-induced inflammatory and apoptotic signaling in neuronal cells
Abstract: Several studies have reported a relation between increased pro-inflammatory mediators such as TNF-α and apoptosis in neurodegenerative diseases such as Alzheimer’s disease (AD). It is known that lipopoly-saccharide (LPS) treatment induces neuroinflammation and memory deterioration, and it has been reported that LPS induces apoptosis mostly through the production of TNF-α. Pentoxifylline (PTX), is a vascular protective agent and a potent TNF-alpha inhibitor. However, the molecular neuroprotective mechanisms of PTX against LPS-induced neurotoxicity have not been well studied. In this study, we investigated the direct protective effect of PTX against LPS-induced toxicity in Rat pheochromocytoma (PC12) cell line. The results showed that a pretreatment with PTX prior exposure to LPS signifycantly decreased LPS-induced cell death. Mechanisms study showed that PTX has the potential to inhibit pro-inflammatory and pro-apoptotic pathways via the suppression of TNF-α and a caspase-dependent pathway in neuronal PC12 cells. This is the first study to report the anti-inflammatory and anti-apoptotic effects of PTX via inhibition of TNF-α and a caspase-dependent pathway in neuronal PC12 cells. Altogether, these observations indicate that PTX is capable of promoting neuroprotective effects, meanwhile also present some insights into the potential signaling pathways that are involved. Thus, these findings support the potential for PTX to be investigated as a potential agent for the treatment of neurodegenerative diseases such as AD.
Cite this paper: Muchhala, S. and Benzeroual, K. (2012) Pentoxifylline suppressed LPS-induced inflammatory and apoptotic signaling in neuronal cells. Advances in Bioscience and Biotechnology, 3, 731-739. doi: 10.4236/abb.2012.326094.

[1]   Forlenza, O.V., Diniz, B.S., Gattaz, W.F. (2010) Diagnosis and biomarkers of predementia in Alzheimer's disease. BMC Med, 8, 89.

[2]   Rohn, T.T., Head, E., Su, J.H., Anderson, A.J., Bahr, B.A., Cotman, C.W. and Cribbs, D.H. (2001) Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease. Am J Pathol, 158(1),189-98.

[3]   Rubio-Perez, J.M. and Morillas-Ruiz, J.M. (2012) A review: Inflammatory process in Alzheimer's disease, role of cytokines. Scientific World Journal, 756357

[4]   Shimohama, S. (2000) Apoptosis in Alzheimer’s disease—an update. Apoptosis, 5, 9–16.

[5]   McGeer, P.L. and McGeer, EG. (2001) Inflammation, autotoxicity and Alzheimer disease. Neurobiol. Aging 2001, 22, 799-809.

[6]   Frankola, K.A., Greig. N.H., Luo. W. and Tweedie. D. (2011) Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS Neurol Disord Drug Targets, 10, 391–403.

[7]   Jellinger, K.A. (2006) Challenges in neuronal apoptosis. Curr Alzheimer Res, 3(4), 377-91.

[8]   Huang, Y.H., Chang, A.Y., Huang, C.M., Huang, S.W. and Chan, S.H. (2002) Proteomic analysis of lipopolysaccharide-induced apoptosis in PC12 cells. Proteomics, 2,1220–1228

[9]   Ansari, N., Khodagholi, F., Amini, M. and Shaerzadeh, F. (2011) Attenuation of LPS-induced apoptosis in NGF-differentiated PC12 cells via NF-κB pathway and regulation of cellular redox status by an oxazine derivative. Biochimie, (93)5, 899-908.

[10]   Michel, O., Kips, J., Duchateau, J., Vertongen, F., Robert, L., Collet, H., Pauwels, R. and Sergysels, R. (1996). Severity of asthma is related to endotoxin in house dust. Am. J. Respir. Crit. Care Med, 154, 1641–1646.

[11]   Kullman, G. J., Thorne, P. S., Waldron, P. F., Marx, J. J., Ault, B., Lewis, D. M., Siegel, P. D., Olenchock, S. A., and Merchant, J. A. (1998). Organic dust exposures from work in dairy barns. Am. Ind. Hyg. Assoc. J, 59, 403–413.

[12]   Choi, S.H., Langenbach, R. and Bosetti, F. (2007) Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury. Faseb J, 22(5), 1491-501

[13]   Rosi, S., Ramirez-Amaya, V., Vazdarjanova, A., Worley, P.F., Barnes, C.A. and Wenk GL. (2005) Neuroinflammation alters the hippocampal pattern of behaviorally induced Arc expression. J Neurosci, 25, 723–731.

[14]   Rosi, S., Vazdarjanova, A., Ramirez-Amaya, V., Worley, P.F., Barnes, C.A. and Wenk, G.L. (2006) Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat. Neuroscience, 142, 1303–1315.

[15]   Rosi, S., Ramirez-Amaya, V., Vazdarjanova, A., Esparza, E.E., Larkin, P.B., Fike, J.R., Wenk, G.L. and Barnes, C.A. (2009) Accuracy of hippocampal network activity is disrupted by neuroinflammation: rescue by memantine. Brain, 132, 2464–2477.

[16]   Bonow, R.H., A?d, S., Zhang, Y., Becker, K.G. and Bosetti, F. (2009) The brain expression of genes involved in inflammatory response, the ribosome, and learning and memory is altered by centrally injected lipopolysaccharide in mice. Pharmacogenomics J, 9, 116–126.

[17]   Shaw, K.N., Commins, S. and O'Mara, S.M. (2001) Lipopolysaccharide causes deficits in spatial learning in the watermaze but not in BDNF expression in the rat dentate gyrus. Behav Brain Res, 124(1), 47–54.

[18]   Hennigan, A., Trotter, C. and Kelly, A.M. (2007) Lipopolysaccharide impairs long-term potentiation and recognition memory and increases p75NTR expression in the rat dentate gyrus. Brain Res, 1130(1), 158–166.

[19]   Hauss-Wegrzyniak, B., Lynch, M.A., Vraniak, P.D. and Wenk, G.L. (2002) Chronic brain inflammation results in cell loss in the entorhinal cortex and impaired LTP in perforant path-granule cell synapses. Exp Neurol, 176, 336–341.

[20]   Lee, J.W., Lee, Y.K., Yuk, D.Y., Choi, D.Y., Ban, S.B., Oh, K.W. and Hong, J.T. (2008) Neuroinflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflammation, 5, 37

[21]   Fillit, H., Ding, W.H., Buee, L., Kalman, J., Altstiel, L., Lawlor, B., Wolf-Klein, G. (1991) Elevated circulating tumor necrosis factor levels in Alzheimer's disease. Neurosci Lett, 129, 318–320.

[22]   Perry, R.T., Collins, J.S., Wiener, H., Acton, R., and Go, R.C.P. (2001) The role of TNF and its receptors in Alzheimer’s disease. Neurobiol Aging, 22, 87-83

[23]   Essayan, D.M (2001) "Cyclic nucleotide phosphodiesterases". J Allergy Clin Immunol, 108 (5), 671–80

[24]   Deree, J., Martins, J.O., Melbostad, H., Loomis, W.H. and Coimbra, R. (2008) "Insights into the Regulation of TNF-α Production in Human Mononuclear Cells: The Effects of Non-Specific Phosphodiesterase Inhibition". Clinics (Sao Paulo), 63 (3), 321–8.

[25]   Ukraintseva, S.V., Arbeev, K.G., Michalsky, A.I. and Yashin, A.I. (2004) Antiaging treatments have been legally prescribed for approximately thirty years. Ann N Y Acad Sci, 1019, 64-9.

[26]   Bluthé, R.M., Frenois, F., Kelley, K.W. and Dantzer, R. (2005) Pentoxifylline and insulin-like growth factor-I (IGF-I) abrogate kainic acid-induced cognitive impairment in mice. J Neuroimmunol, 169(1-2), 50-8.

[27]   Stüber, E., Büschenfeld, A., von Freier, A., Arendt, T. and F?lsch, U.R. (1999) Intestinal crypt cell apoptosis in murine acute graft versus host disease is mediated by tumour necrosis factor α and not by the FasL-Fas interaction: effect of pentoxifylline on the development of mucosal atrophy. Gut, 45, 229-235

[28]   Belloc, F., Jaloustre, C., Dumain, P., Lacombe, F., Lenoble, M., Boisseau, M.R. (1995) Effect of pentoxifylline on apoptosis of cultured cells. J Cardiovasc Pharmacol, 25(2), S71-4.

[29]   Rüdiger, H.A., Clavien, P.A. (2002) Tumor necrosis factor alpha, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology, 122(1), 202-10.

[30]   Girish, V., and Vijayalakshmi, A. (2004). Affordable image analysis using NIH Image/ImageJ. Indian J. Cancer, 41, 47.

[31]   Korsmeyer, S.J., Shutter, J.R., Veis, D.J., Merry, D.E., and Oltvai, Z.N.(1993) Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death, Semin. Cancer Biol, 4, 327–332.

[32]   Sharifi, A.M., Hoda. F.E. and Noor, A.M. (2010) Studying the effect of LPS on cytotoxicity and apoptosis in PC12 neuronal cells: role of Bax, Bcl-2, and Caspase-3 protein expression. Toxicol Mech Methods, 20 (6), 316-20.

[33]   Dholakiya, S., and Benzeroual, K.E. (2011) Protective effect of Diosmin on LPS-induced apoptosis in PC12 cells and inhibition of TNF-a expression. Toxicology In Vitro, 25(5), 1039-44.

[34]   Miller, D.K. (1997) The role of caspase family of cysteine proteases in apoptosis, Semin. Immunol. 9, 35–49.

[35]   Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D. and Perry, V.H. (2009) Systemic inflammation and disease progression in Alz-heimer disease. Neurology, 73(10), 768-74.

[36]   Tweedie, D., Ferguson, R.A., Fishman, K., Frankola, K.A., Van Praag, H., Holloway, H.W., Luo, W., Li, Y., Caracciolo, L., Russo, I., Barlati, S., Ray, B., Lahiri, D.K., Bosetti, F., Greig, N.H. and Rosi S. (2012) Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease. J Neuroinflammation. 9,106.

[37]   Uberti, D., Ferrari-Toninelli, G., Bonini, S.A., Sarnico, I., Benarese, M., Pizzi, M., Benussi, L., Ghidoni, R., Binetti, G., Spano, P., Facchetti, F. and Memo, M. (2007) Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity. Neuropsychopharmacology, 32(4), 872-80.

[38]   Calissano, P., Matrone, C. and Amadoro, G. (2009). Apoptosis and in vitro Alzheimer disease neuronal models. Commun. Integr. Biol, 2, 163–169.

[39]   Tarkowski, E., Liljeroth, A.M., Minthon, L., Tardowski, A., Wallin, A. and Blennow, K. (2003) Cerebral pattern of pro- and anti-inflammatory cytokines in dementias. Brain Res Bull, 61 (3), 255-260.

[40]   Culpan, D., Cornish, A., Love, S., Kehoe, P.G. and Wilcock, G.K. (2007) Protein and gene expression of tumor necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease, Exp. Gerontol, 42(6), 538–544.

[41]   Tarkowski, E., Andreasen, N., Tarkowski, A. and Blennow, K. (2003) Intrathecal inflammation precedes development of Alzheimer’s disease. J Neurol Neurosurg Psychiatry,74, 1200–1205.

[42]   Alvarez, A., Cacabelos, R., Sanpedro, C., García-Fantini, M. and Aleixandre, M. (2007) Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiol Aging, 28(4), 533-6.

[43]   Wong, P.M.C., Chung, S.W. and Sultzer, B.M. (2000) Genes, receptors, signals and responses to lipopolysaccharide endotoxin. Scand J Immunol, 51, 123-127.

[44]   Tweedie, D., Sambamurti, K. and Greig, N.H. (2007) TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets, Curr. Alzheimer Res, 4, 378–385.

[45]   Greene, L.A. and Tischler A. (1976) Establishment of a noradrenergic cell line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl Acad. Sci, 73, 2424—2428.

[46]   Farinelli, S. E., Park D. S. and Greene L. A. (1996) Nitric oxide delays the death of trophic factor deprived PC 12 cells and sympathetic neurons by a cGMP-mediated mechanism. J. Neurosci, 16, 2325—2334.

[47]   Park, K.M. and Bowers, W.J. (2010) Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction. Cell Signal, 22, 977–983.

[48]   Wang, M., Chen, Y., Zhang, Y., Zhang, L., Lu, X. and Chen, Z. (2011) Mannan-binding lectin directly interacts with Toll-like receptor 4 and suppresses lipopolysaccharide-induced inflammatory cytokine secretion from THP-1 cells. Cellular & Molecular Immunology, 8(3), 265-75.

[49]   Xie, Z., Wei. M., Morgan, T.E., Fabrizio, P., Han, D., Finch, C.E. and Longo, V.D. (2002) Peroxynitrite mediates neurotoxicity of amyloid beta-peptide1-42-and lipopolysaccharide-activated microglia. J Neurosci, 22(9), 3484-92.

[50]   Liu, X., Zou, H., Slaughter, C. and Wang, X. (1997). DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell, 89, 175-84.

[51]   Lavrik, I.N., Golks, A. and Krammer, P.H. (2005) Caspases: pharmacological manipulation of cell death. J. Clin. Invest, 15, 2665-2672.

[52]   Zhu, D.J., Xia, B., Bi, Q., Zhang, S.J., Qiu, B.S. and Zhao, C. (2008) Functional protection of pentoxifylline against spinal cord ischemia/reperfusion injury in rabbits: necrosis and apoptosis effects. Chin Med J, 121(23), 2444-9.

[53]   Solerte, S.B., Ceresini, G., Ferrari, E. and Fioravanti, M. (2000) Hemorheological changes and overproduction of cytokines from immune cells in mild to moderate dementia of the Alzheimer's type: adverse effects on cerebromicrovascular system. Neurobiol Aging, 21(2), 271-81.

[54]   Romàn, G. (2000) Perspectives in the treatment of vascular dementia. Drugs Today, 36(9), 641-53.

[55]   Pantoni, L. (2004) Treatment of vascular dementia: evidence from trials with non-cholinergic drugs. J Neurol Sci, 226(1-2), 67-70..